* I et lille antal post- marketing- forsøg og kliniske forsøg med alle PDE- hæmmere, herunder sildenafil, er der set pludselig nedsættelse eller tab af hørelse.
* Sudden decrease or loss of hearing has been reported in a small number of post-marketing and clinical trial cases with the use of all PDE5 inhibitors, including sildenafil.